The YEL053W-A Antibody (Product Code: CSB-PA546003XA01SVG) is designed for detecting the YEL053W-A protein, a hypothetical ORF in the yeast genome. Key specifications include:
| Parameter | Value |
|---|---|
| Target Antigen | YEL053W-A (UniProt ID: A0A023PXC2) |
| Host Species | Rabbit |
| Clonality | Polyclonal |
| Applications | Western Blot (WB), ELISA |
| Tested Species Reactivity | Saccharomyces cerevisiae (Baker’s yeast) |
| Storage | 2 ml or 0.1 ml aliquots, stable at -20°C |
Source: Cusabio Product Catalog
YEL053W-A is an uncharacterized protein encoded by an open reading frame (ORF) in S. cerevisiae. Its functional role remains undetermined, though genomic context suggests potential involvement in:
Metabolic regulation: Proximity to genes linked to carbohydrate metabolism.
Stress response: Hypothesized interactions with chaperone proteins.
No structural or functional studies for YEL053W-A are publicly documented, highlighting a gap in current yeast proteome research .
The immunogen is a synthesized peptide derived from the YEL053W-A sequence. Polyclonal antibodies are generated through repeated immunization, followed by affinity purification.
Specificity: Lack of knockout (KO) yeast strains for YEL053W-A complicates specificity testing.
Cross-reactivity: Risk of epitope sharing with homologous yeast proteins (e.g., YEL054C).
Application Limitations: Performance may vary in immunofluorescence (IF) or immunoprecipitation (IP) due to insufficient validation data .
Western Blot: Use lysates from wild-type and YEL053W-AΔ strains (if available) to confirm specificity.
ELISA: Quantify protein expression under stress conditions (e.g., heat shock, nutrient deprivation).
Negative Controls: Include secondary antibody-only and non-transfected lysates.
Orthogonal Validation: Pair with RNA-seq or proteomics data to correlate expression levels .
Functional Studies: CRISPR/Cas9-mediated KO strains could elucidate YEL053W-A’s role.
Structural Biology: Cryo-EM or X-ray crystallography of the antibody-antigen complex would resolve binding mechanics.
Comparative Analysis: Cross-reactivity screens against yeast homologs (e.g., YFL012W-A) are warranted .
YEL053W-A is a gene found in Saccharomyces cerevisiae (baker's yeast), coding for a putative protein whose function is still being characterized. Researchers use antibodies against YEL053W-A primarily for studying gene expression patterns in yeast under various stress conditions and for investigating protein-protein interactions.
The protein encoded by YEL053W-A is of interest to researchers studying fundamental cellular processes in yeast, as it may be involved in stress response pathways. Similar to other yeast genes like YEL030C-A , antibodies against YEL053W-A enable the detection, localization, and characterization of the expressed protein in various experimental setups.
Validating antibody specificity is critical for ensuring reliable experimental results. For YEL053W-A antibody, consider these validation approaches:
Genetic validation: Use a YEL053W-A knockout strain as a negative control. The absence of signal in these samples confirms specificity .
Western blotting: Compare wild-type versus knockout yeast strains to verify that the antibody recognizes a protein of the expected molecular weight.
Cross-reactivity testing: Test against closely related yeast proteins, particularly if YEL053W-A has paralogs or similar domains to other proteins.
Immunoprecipitation followed by mass spectrometry: Verify that the antibody pulls down the intended protein rather than off-target proteins.
Epitope mapping: Identify the specific region of YEL053W-A recognized by the antibody to predict potential cross-reactivity with other proteins.
As emphasized in recent literature on antibody validation, using multiple validation methods substantially improves confidence in antibody specificity .
YEL053W-A antibody can be employed in several experimental applications:
For protein localization studies, immunofluorescence microscopy using fixed yeast cells provides valuable insights into the subcellular distribution of YEL053W-A protein under different conditions .
The epitope characteristics of YEL053W-A significantly impact antibody binding efficiency and experimental outcomes:
Epitope accessibility: The three-dimensional structure of YEL053W-A protein determines whether the epitope is exposed or buried. Similar to studies on CD43 antibodies, epitopes influenced by post-translational modifications like glycosylation may affect antibody recognition .
Linear vs. conformational epitopes: Polyclonal antibodies against YEL053W-A typically recognize multiple epitopes, including both linear and conformational epitopes, providing robust detection across different experimental conditions.
Post-translational modifications: If YEL053W-A undergoes phosphorylation, glycosylation, or other modifications under specific conditions, antibody binding may be affected. For example, some antibodies show sensitivity to sialic acid elimination while others do not .
Native vs. denatured conditions: Consider whether your antibody recognizes the native protein structure (better for immunoprecipitation) or denatured protein (better for Western blotting).
Understanding these characteristics helps in selecting appropriate experimental conditions for optimal antibody performance.
Proper controls are essential for interpreting results obtained with YEL053W-A antibody:
Positive controls:
Wild-type yeast strain expressing YEL053W-A
Recombinant YEL053W-A protein (if available)
Yeast strain with YEL053W-A tagged with a well-characterized epitope (e.g., FLAG, HA)
Negative controls:
YEL053W-A knockout strain
Pre-immune serum (for polyclonal antibodies)
Isotype control (for monoclonal antibodies)
Secondary antibody only
Procedural controls:
Loading control antibodies (e.g., anti-actin, anti-tubulin) for Western blots
Competition assay with purified antigen to confirm specificity
Non-related yeast proteins to assess cross-reactivity
Including these controls helps distinguish genuine signals from background and confirms antibody specificity in each experimental context.
Developing antibodies against yeast proteins presents several unique challenges:
Evolutionary conservation: Many yeast proteins share significant homology with proteins in other species, making it difficult to generate highly specific antibodies. Careful epitope selection is required to avoid cross-reactivity .
Low immunogenicity: Some yeast proteins may have low immunogenicity in mammalian hosts used for antibody production, resulting in weak immune responses. Coupling to carrier proteins or using adjuvants may improve immunogenicity.
Post-translational modifications: Yeast proteins produced in bacteria for immunization may lack native post-translational modifications, potentially affecting epitope recognition in native proteins .
Protein expression levels: YEL053W-A may be expressed at low levels under standard conditions, making antibody validation challenging. Consider using strains with upregulated expression for initial validation.
Protein solubility: Some yeast proteins may be difficult to purify in their native conformation, limiting the quality of antigens used for immunization.
These challenges can be addressed through careful immunization strategies, screening methods, and thorough validation protocols.
Cross-reactivity can compromise experimental results. If you encounter cross-reactivity with your YEL053W-A antibody, consider these troubleshooting approaches:
Epitope mapping: Identify which part of YEL053W-A your antibody recognizes and compare this sequence with other yeast proteins to predict potential cross-reactivity.
Blocking optimization: Test different blocking agents (BSA, milk, commercial blockers) to reduce non-specific binding.
Antibody purification: Consider affinity purification of the antibody against the specific antigen to enrich for antibodies that recognize the target protein.
Preabsorption: Incubate the antibody with lysates from YEL053W-A knockout strains to remove antibodies that bind to unrelated proteins.
Alternative antibodies: If available, test different antibody clones or those raised against different epitopes of YEL053W-A.
Validation in knockout strains: Conclusively demonstrate specificity by comparing signal in wild-type versus YEL053W-A knockout strains .
Titration: Optimize antibody concentration to maximize specific signal while minimizing background.
Sample preparation significantly impacts YEL053W-A antibody performance across different applications:
Cell lysis methods:
Mechanical disruption (e.g., glass beads) preserves protein structure but may be less efficient
Chemical lysis (e.g., detergents) may denature proteins, affecting conformational epitopes
Enzymatic methods (e.g., zymolyase) are gentler but may impact some protein modifications
Buffer composition:
For yeast cells, protocols typically use buffers containing:
Protease inhibitors to prevent protein degradation
Phosphatase inhibitors if phosphorylation status is important
EDTA to inhibit metalloproteases
Appropriate detergents for membrane protein solubilization
Fixation for microscopy:
Paraformaldehyde preserves structure but may mask some epitopes
Methanol fixation enhances penetration but can denature proteins
Cold acetone may be preferable for certain yeast epitopes
Protein denaturation:
Heat denaturation (95°C) enhances some epitope accessibility but destroys others
Reducing agents affect disulfide bonds, altering protein conformation
For optimal results with yeast proteins like YEL053W-A, methods detailed in established yeast protocols should be followed, with appropriate modifications based on the specific characteristics of your antibody.
YEL053W-A antibody can be valuable for investigating stress response mechanisms in yeast:
Temporal expression analysis: Monitor YEL053W-A protein levels at different time points following stress exposure (heat shock, oxidative stress, nutrient deprivation) using Western blotting.
Subcellular localization changes: Track potential relocalization of YEL053W-A during stress using immunofluorescence microscopy. Similar to other yeast proteins studied under stress conditions, YEL053W-A may exhibit dynamic localization patterns .
Protein-protein interactions: Use YEL053W-A antibody for co-immunoprecipitation to identify interaction partners under normal versus stress conditions.
Chromatin association: If YEL053W-A is involved in transcriptional regulation during stress, chromatin immunoprecipitation (ChIP) can identify its genomic binding sites.
Post-translational modifications: Combine YEL053W-A antibody with modification-specific detection methods to monitor changes in phosphorylation, ubiquitination, or other modifications during stress response.
Research on yeast stress response pathways has shown that many proteins undergo significant changes in abundance, localization, and modification state under stress conditions . YEL053W-A antibody enables detailed characterization of this protein's role in these essential cellular processes.
Integrating YEL053W-A antibody with advanced techniques provides deeper insights:
Proximity labeling approaches:
BioID or APEX2 fusions with YEL053W-A can identify proximal proteins when combined with antibody-based detection
This reveals the protein's microenvironment and transient interactions
CRISPR-based genomic tagging:
Tag endogenous YEL053W-A with fluorescent proteins or epitope tags
Use anti-YEL053W-A antibody to verify expression and localization of the tagged protein
Super-resolution microscopy:
Combine YEL053W-A antibody with super-resolution techniques (STORM, PALM, SIM)
Provides nanoscale resolution of protein distribution not possible with conventional microscopy
Mass spectrometry integration:
Immunoprecipitate YEL053W-A followed by mass spectrometry
Identifies post-translational modifications and interaction partners
Single-cell analysis:
Use YEL053W-A antibody in flow cytometry or CyTOF
Quantifies protein levels across heterogeneous yeast populations
Microfluidics-based approaches:
Combine with microfluidic devices to study protein dynamics in response to rapidly changing environmental conditions
Sandwich ELISA development: